Research ArticleBRAIN
Multiple Sclerosis and Alzheimer Disease through the Looking Glass of MR Imaging
Giovanni B. Frisoni and Massimo Filippi
American Journal of Neuroradiology November 2005, 26 (10) 2488-2491;

References
- ↵Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia 1994;35:S72–S89
- ↵Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28–37
- ↵
- ↵Jack CR Jr, Petersen RC, O’Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 1992;42:183–188
- ↵Jobst KA, Smith AD, Szatmari M, et al. Detection in life of confirmed Alzheimer’s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179–1183
- ↵Smith AD. Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci USA 2002;99:4135–4137
- ↵Ashburner J, Csernansky JG, Davatzikos C, et al. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003;2:79–88
- ↵Frisoni GB, Testa C, Zorzan A, et al. Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002;73:657–664
- ↵
- ↵Mandelkow EM, Stamer K, Vogel R, et al. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 2003;24:1079–1085
- ↵van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747–754
- ↵Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400
- ↵Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295–302
- ↵Filippi M, Rovaris M, Inglese M, et al. Reduced brain tissue loss during randomised study of interferon β-1a in patients at presentation with syndromes suggestive of multiple sclerosis. Lancet 2004;364:1489–1496
- ↵Filippi M, Bozzali M, Rovaris M, et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 2003;126:433–437
- ↵Inglese M, Ge Y, Filippi M, et al. Indirect evidence for early widespread gray matter involvement in relapsing remitting multiple sclerosis. NeuroImage 2004;21:1825–1829
- ↵Coles AJ, Wing MG, Molyneux P, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999;46:296–304
- ↵Itagaki S, McGeer PL, Akiyama H, et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173–182
- ↵Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461–467
- ↵
- ↵Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer’s disease. Lancet Neurol 2002;1:279–284
- ↵Filippi M, Rovaris M, Comi G, eds. Normal-appearing white and grey matter damage in multiple sclerosis. Springer-Verlag: Milan;2004
- ↵Iannucci G, Rovaris M, Giacomotti L, et al. Correlations between measures of multiple sclerosis pathology derived from T2, T1, magnetization transfer and diffusion tensor MR imaging. AJNR Am J Neuroradiol 2001;22:1462–1467
- ↵Filippi M, Tortorella C, Rovaris M, et al. Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157–161
- ↵Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391–395
- ↵Rovaris M, Filippi M. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr Opin Neurol 1999;12:337–344
- ↵Bozzali M, Falini A, Franceschi M, et al. White matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002;72:742–746
- Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750–757
- ↵Laakso MP, Hallikainen M, Hanninen T, et al. Diagnosis of Alzheimer’s disease: MRI of the hippocampus vs delayed recall. Neuropsychologia 2000;38:579–584
- ↵Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer’s disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40–47
- ↵Hanyu H, Asano T, Iwamoto T, et al. Magnetization transfer measurements of the hippocampus in patients with Alzheimer’s disease, vascular dementia, and other types of dementia. AJNR Am J Neuroradiol 2000;21:1235–1242
- ↵Mori E, Yoneda Y, Yamashita H, et al. Medial temporal structures relate to memory impairment in Alzheimer’s disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry 1997;63:214–221
- ↵Robert PhH, Verhey FRJ, Byrne EJ, et al. Grouping for behavioural and psychological symptoms in dementia: clinical and biological aspects: consensus paper of the European Alzheimer’s Disease Consortium (EADC). Eur Psychiatry 2005 (in press)
- ↵Hanyu H, Asano T, Sakurai H, et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer’s disease. J Neurol Sci 1999;167:37–44
- MacKay S, Meyerhoff DJ, Constans JM, et al. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996;53:167–74
- ↵Yoshiura T, Mihara F, Ogomori K, et al. Diffusion tensor in posterior cingulate gyrus: correlation with cognitive decline in Alzheimer’s disease. Neuroreport 2002;13:2299–2302
- ↵Bartzokis G, Sultzer D, Lu PH, et al. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease. Neurobiol Aging 2004;25:843–851
- ↵Uchihara T, Kondo H, Akiyama H, Ikeda K. White matter amyloid in Alzheimer’s disease brain. Acta Neuropathol 1995;90:51–56
- ↵Filippi M. Magnetic resonance imaging findings predicting subsequent disease course in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neurol Sci 2001;22:S49–S51
- ↵Brex PA, Ciccarelli O, O’Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158–164
- ↵McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–127
- ↵Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397–1403
- ↵Riemenschneider M, Lautenschlager N, Wagenpfeil S, et al. Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 2002;59:1729–1734
- ↵Chetelat G, Desgranges B, De La Sayette V, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 2003;60:1374–1377
- ↵Okamura N, Arai H, Maruyama M, et al. Combined analysis of CSF tau levels and [(123)I]iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer’s disease. Am J Psychiatry 2002;159:474–476
- ↵Citron M. Alzheimer’s disease: treatments in discovery and development. Nat Neurosci 2002;5:1055–1057
- ↵Filippi M, Rocca MA. Cortical reorganisation in patients with MS: using functional MRI techniques to study patients with MS. J Neurol Neurosurg Psychiatry 2004;75:1087–1089
- ↵Saykin AJ, Flashman LA, Frutiger SA, et al. Neuroanatomic substrates of semantic memory impairment in Alzheimer’s disease: patterns of functional MRI activation. J Int Neuropsychol Soc 1999;5:377–392
- Prvulovic D, Hubl D, Sack AT, et al. Functional imaging of visuospatial processing in Alzheimer’s disease. Neuroimage 2002;17:1403–1414
- Lustig C, Snyder AZ, Bhakta M, et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci USA 2003;100:1454–1459
- ↵Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004;56:27–35
- ↵De Vreese LP, Neri M, Fioravanti M, et al. Memory rehabilitation in Alzheimer’s disease: a review of progress. Int J Geriatr Psychiatry 2001;16:794–809
- ↵Barkhof F, Filippi M, Miller DH, et al. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 1997;244:76–84
- ↵Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147–1153
- ↵Mayeux R, Sano M. Treatment of Alzheimer’s disease. N Engl J Med 1999;341:1670–1679
- ↵Growdon JH. Incorporating biomarkers into clinical drug trials in Alzheimer’s disease. J Alzheimers Dis 2001;3:287–292
- ↵Nordberg A. PET imaging of amyloid in Alzheimer’s disease. Lancet Neurol 2004;3:519–527
In this issue
Advertisement
Giovanni B. Frisoni, Massimo Filippi
Multiple Sclerosis and Alzheimer Disease through the Looking Glass of MR Imaging
American Journal of Neuroradiology Nov 2005, 26 (10) 2488-2491;
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement